Baschnagel, A.M.
~ 200  results:
Search for persons X
?
1

Leveraging Quantitative Imaging and Machine Learning to Dif..:

Basree, M.M. ; Li, C. ; Bui, A.H....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e85-e86 , 2023
 
?
2

Longitudinal Radiomics-Based Prediction of Local Recurrence..:

Liu, M. ; Li, C. ; Menon, H....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e39 , 2023
 
?
3

Treatment Efficacy Outcomes Combining Dual Checkpoint Immun..:

Morris, B.A. ; Leal, T.A. ; Sethakorn, N....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S128-S129 , 2023
 
?
4

Initial Results of a Phase II Trial of Hypofractionated Rad..:

Eckelmann, B.J. ; Blitzer, G.C. ; Smilowitz, J.B....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S147-S148 , 2023
 
?
5

EP14.03-001 DARES: A Phase II Trial of Durvalumab and Ablat..:

Juloori, A. ; Gan, G. ; Zhang, J....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S540 , 2022
 
?
6

Dose to High Ventilating Lung Predicts Radiation-Induced Pn..:

Flakus, M.J. ; Wallat, E. ; Wuschner, A.E....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S60 , 2022
 
?
7

Immune-Depleted Phenotype in Non-Small Cell Lung Cancer Bra..:

Rydzewski, N.R. ; Buehler, D. ; Kendziorski, C....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. S14 , 2021
 
?
8

Interim Results of a Phase II Trial on Hypofractionated Rad..:

Blitzer, G.C. ; Yadav, P. ; Bayouth, J....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. e314-e315 , 2021
 
?
9

Detection of MR Imaging Differences of Metastatic Intracran..:

Morris, B.A. ; Premkumar, H. ; Enright, T....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. e575 , 2021
 
?
10

Quantitative CT Assessment of Emphysema in Medically Inoper..:

Merfeld, E. ; Yadav, P. ; Rottier, A....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e108 , 2020
 
?
11

Density of Immunosuppressive FOXP3+ and CD4+ Tumor Infiltra..:

Witt, J.S. ; Emmerich, P. ; Jagodinsky, J.C....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. S83-S84 , 2020
 
?
12

Radiomic Features Predict Rib Fracture after Stereotactic B..:

Rydzewski, N.R. ; Yadav, P. ; Musunuru, H.B....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e785 , 2020
 
?
13

Immunotherapy Combined with Stereotactic Radiotherapy Impro..:

Enright, T. ; Witt, J.S. ; Burr, A....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e97 , 2020
 
?
14

Decreased Treatment Volumes are Possible with MIBH MRgRT Co..:

Yadav, P. ; Burr, A. ; Lee, S.L....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. S78 , 2020
 
?
15

CD44 Expression Is Correlated With MTOR Expression And p16 ..:

Arden, J.D. ; Quinn, T.J. ; Wilson, T.G....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e505 , 2020
 
1-15